Skip to content

ETFs compared

Costs, returns, risk and composition side by side, plus how much the holdings overlap.

Amundi Prime Europe UCITS ETF DR (C)Amundi Prime Europe UCITS ETF DR (D)

Performance

  • Amundi Prime Europe UCITS ETF DR (C)
  • Amundi Prime Europe UCITS ETF DR (D)

From 18 November 2021. With distributions reinvested.

Key figures

PRAE.DEAmundi Prime Europe UCITS ETF DR (C)PR1E.DEAmundi Prime Europe UCITS ETF DR (D)
Costs and fund
Costs (TER)0.05%0.05%
Costs per year on €10,000€5.00€5.00
Fund size€758.63M€758.63M
Holdings386386
Top 10 share21.8%21.8%
Distribution policyAccumulatingDistributing
ProviderAmundiAmundi
ReplicationPhysicalPhysical
DomicileLuxembourgLuxembourg
LaunchedJan 2020Feb 2019
Score and risk
Holdings score7070
Crash risk5%5%
Largest drop in 10 years−36.0%−36.0%
Volatility 1 year13.2%13.0%
Returns
Return 1 year+17.5%+17.5%
3 years p.a.+17.9%+17.9%
5 years p.a.+9.8%+9.8%
10 years p.a.no datano data

Green marks the best value in each row. Crash risk counts how often the ETF fell by 30% or more within 12 months over the last ten years, with distributions reinvested. If its history is shorter, the longest history of an ETF on the same index counts, or failing that, the same fund on another exchange in the same currency.

Countries

PRAEPR1E
United Kingdom21.9%22.0%
Switzerland15.0%15.1%
Germany13.6%13.4%
France12.1%12.2%
Netherlands8.2%8.0%
Sweden6.0%6.0%
Spain5.5%5.6%
Italy4.6%4.6%
Denmark2.6%2.7%
United States2.3%2.4%

Sectors

PRAEPR1E
Financial Services24.7%24.7%
Industrials17.8%17.8%
Healthcare14.5%14.5%
Consumer Defensive8.9%8.9%
Technology8.7%8.7%
Consumer Cyclical6.1%6.1%
Energy5.8%5.8%
Basic Materials4.9%4.9%
Utilities4.7%4.7%
Communication Services3.6%3.6%

Holdings overlap

For every common holding the smaller of the two weights counts. 100% would mean identical content, 0% nothing in common.

PRAE.DEandPR1E.DE
99%
98.8% invested alike, 386 holdings in common
Largest common holdingsPRAEPR1E
ASML Holding N.V.4.20%4.20%
Roche Holding AG2.49%2.49%
HSBC HOLDINGS PLC2.23%2.23%
Novartis AG2.15%2.15%
ASTRAZENECA GBP2.02%2.02%

Returns with distributions reinvested, in the trading currency; the price chart shows the traded price. Master data and holdings from FMP. Not investment advice.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy